Atrion Corporation (ATRI)

Market Cap	805.44M
Revenue (ttm)	176.67M
Net Income (ttm)	18.72M
Shares Out	1.76M
EPS (ttm)	10.64
PE Ratio	43.03
Forward PE	n/a
Dividend	$8.80 (1.92%)
Ex-Dividend Date	Jun 14, 2024

Volume	17,343
Open	457.60
Previous Close	457.65
Day's Range	457.60 - 458.01
52-Week Range	274.98 - 575.88
Beta	0.69
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2024

About ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company’s fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiova...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1944
• Employees: 712
• Stock Exchange: NASDAQ
• Ticker Symbol: ATRI

Financial Performance

In 2023, Atrion's revenue was $169.33 million, a decrease of -7.73% compared to the previous year's $183.51 million. Earnings were $19.41 million, a decrease of -44.55%.